Exchange: NASDAQ·Updated 03:05 PM EDT
BNTC logo

BNTC Benitec Biopharma Inc

$11.34
$0.74
(6.13%)
Today
EarningsNov 12
Mkt Cap$415M
Vol173,361.00

About BNTC

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.
56

Bullish Sentiment

How do you feel about BNTC?

Advertisement|Remove ads.